Mankind Pharma Ltd

Mankind Pharma Ltd

Fortune 500 2024
+ 2 More
+ 2 More
OVERVIEW
FINANCIALS
NEWS

Featured In Fortune India Ranking

Fortune 500 India
#227(2024)
#250(2023)
#213(2022)
#227(2024)#250(2023)#213(2022)
Ranking Trend Fortune 500 India

Financial Data 2024

Revenue
10,726
(INR Cr)
Net Operating Income
10,335
(INR Cr)
Assets
9,929
(INR Cr)
Profit
1,913
(INR Cr)
Net Worth
9,363
(INR Cr)

Fortune India Coverage

Financial Data

RevenueNet Operating IncomeProfitAssetsNet Worth
PARAMETERS2024202320222021202020192018201720162015201420132012201120102009
Revenue
(INR Cr)
10726
24.7%
8601
1.9%
8442
27.1%
6644
10.8%
5998
54.9%
3871
-4.4%
4050
9.6%
3695
14.1%
3238
-7.5%
3500
49.1%
2348
19.8%
1959
11.2%
1762
14.6%
1538
35.7%
1133
29.0%
878
-
Net Operating Income
(INR Cr)
10335
18.12%
8749
12.44%
7782
25.22%
6214
5.95%
5865
0.00%
3829
-2.27%
3918
12.12%
3495
10.96%
3150
17.41%
3334
0.00%
2289
16.35%
1967
19.17%
1651
17.32%
1407
29.57%
1086
29.22%
840
34.47%
Profit
(INR Cr)
1913
49.2%
1282
-10.6%
1433
13.3%
1265
22.8%
1030
100.5%
514
-26.0%
694
30.6%
532
12.0%
475
8.1%
439
27.6%
344
18.5%
291
36.0%
214
3.3%
207
20.3%
172
42.7%
121
-
Assets
(INR Cr)
9929
25.4%
7917
8.6%
7290
40.6%
5185
33.5%
3884
17.8%
3297
-2.7%
3390
27.4%
2662
25.7%
2118
-0.2%
2122
34.1%
1582
28.2%
1235
31.0%
943
29.0%
731
45.2%
504
47.7%
341
-
Net Worth
(INR Cr)
9363
25.9%
7435
20.8%
6155
30.4%
4722
35.5%
3485
0.0%
3065
2.3%
2997
13.6%
2639
25.5%
2102
7.3%
2055
0.0%
1556
28.4%
1211
31.6%
921
30.3%
707
41.4%
500
49.8%
334
52.3%
Employee Cost
(INR Cr)
2275
18.6%
1918
18.4%
1621
14.5%
1416
6.0%
1336
70.1%
785
-1.6%
798
20.5%
663
15.6%
573
-0.7%
577
62.8%
354
18.5%
299
26.2%
237
26.0%
188
34.5%
140
35.6%
103
-
Interest Cost
(INR Cr)
35466021234018122221222
Cash & Bank Balance
(INR Cr)
11984534067014207281926939100105898310060
Total Debt
(INR Cr)
207170873241131190360000000147

Key Financial Ratios

Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
PARAMETERS2024202320222021202020192018201720162015201420132012201120102009
Profit As % Of Revenues 17.8%14.9%17.0%19.0%17.2%13.3%17.1%14.4%14.7%12.6%14.7%14.8%12.1%13.5%15.2%13.7%
Profit As % Of Assets 19.3%16.2%19.7%24.4%26.5%15.6%20.5%20.0%22.4%20.7%21.8%23.5%22.7%28.3%34.2%35.4%
Profit As % Of Networth 20.4%17.2%23.3%26.8%29.6%16.8%23.2%20.2%22.6%21.4%22.1%24.0%23.2%29.3%34.4%36.1%
Interest Cost to EBITDA % 1.4%2.4%3.0%1.3%1.6%5.6%2.3%0.2%0.3%0.4%0.4%0.4%0.5%0.6%0.6%1.4%
Debt to Equity Ratio 0.020.020.140.050.040.060.12-0.000.000.00--0.000.010.02
RONW 23.1%19.3%26.7%31.5%30.3%17.0%24.6%22.4%23.4%21.6%24.9%27.3%26.3%34.3%41.3%43.6%
ROCE 27.9%23.1%33.4%39.2%39.5%21.9%31.7%32.4%33.5%29.6%34.6%36.6%33.4%47.0%59.4%66.0%